TrialInternational journal of cancer2026

Efficacy and safety of fruquintinib combined with albumin-bound paclitaxel as second-line therapy for advanced gastric cancer following failure of PD-1 inhibitor-containing treatment (TACTIC GC-01): A phase II single-arm study.

Xiaoting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.